South Sudan vs Venezuela: The number of people with susceptibility test result for rifampicin
South Sudan
0
in 2021
Venezuela
3.31
in 2021
South Sudan rank
142nd
Venezuela rank
140th
The number of people with susceptibility test result for rifampicin over time
- South Sudan
- Venezuela
How they compare
Venezuela currently reports 3.31 against 0 in South Sudan, a difference of 3.31.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Venezuela ahead.
South Sudan ranks 142nd and Venezuela ranks 140th of 146 countries.
Venezuela has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Sudan | Venezuela | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.82 | 5.64 | 3.82 | Venezuela |
| 2020s | 2.31 | 2.56 | 0.2596 | Venezuela |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, South Sudan or Venezuela?
- Venezuela, at 3.31 against 0 in South Sudan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between South Sudan and Venezuela?
- 3.31, with Venezuela ahead.
- How many years of comparable data are there for South Sudan and Venezuela?
- 5 years are reported by both, from 2017 to 2021.
- How do South Sudan and Venezuela rank globally for the number of people with susceptibility test result for rifampicin?
- South Sudan ranks 142nd and Venezuela ranks 140th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.